These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25724826)

  • 1. In vitro and in silico evaluation of twelve newly-synthesized 1-acetamide-5-methoxy-2-oxindoles as 5-Ht₇ receptor ligands.
    Díaz-Cervantes E; Islas-Jácome A; Rentería-Gómez A; Robles J; Gámez-Montaño R
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1580-5. PubMed ID: 25724826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spiro[pyrrolidine-3,3'-oxindoles] as 5-HT
    Kelemen ÁA; Satała G; Bojarski AJ; Keserű GM
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2418-2421. PubMed ID: 29910079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
    Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N₁-arylsulfonyl indole derivatives as 5-HT₆ receptor ligands.
    Nirogi RV; Badange R; Kambhampati R; Chindhe A; Deshpande AD; Tiriveedhi V; Kandikere V; Muddana N; Abraham R; Khagga M
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7431-5. PubMed ID: 23141912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spiro[pyrrolidine-3,3'-oxindoles] and Their Indoline Analogues as New 5-HT6 Receptor Chemotypes.
    Kelemen ÁA; Satala G; Bojarski AJ; Keserű GM
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29240714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of azepino[4,5-b]indol-4-ones via MCR/free radical cyclization and in vitro-in silico studies as 5-Ht₆R ligands.
    Rentería-Gómez A; Islas-Jácome A; Díaz-Cervantes E; Villaseñor-Granados T; Robles J; Gámez-Montaño R
    Bioorg Med Chem Lett; 2016 May; 26(9):2333-8. PubMed ID: 26996373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the development of 5-HT₇ ligands combining serotonin-like and arylpiperazine moieties.
    Spadoni G; Bedini A; Bartolucci S; Pala D; Mor M; Riccioni T; Borsini F; Cabri W; Celona D; Marzi M; Tarzia G; Rivara S; Minetti P
    Eur J Med Chem; 2014 Jun; 80():8-35. PubMed ID: 24763360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and pharmacological evaluation of conformationally restricted N-arylsulfonyl-3-aminoalkoxy indoles as a potential 5-HT6 receptor ligands.
    Nirogia RV; Kambhampati R; Daulatabad AV; Gudla P; Shaikh M; Achanta PK; Shinde AK; Dubey PK
    J Enzyme Inhib Med Chem; 2011 Jun; 26(3):341-9. PubMed ID: 21524149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor.
    Pessoa-Mahana H; González-Lira C; Fierro A; Zapata-Torres G; Pessoa-Mahana CD; Ortiz-Severin J; Iturriaga-Vásquez P; Reyes-Parada M; Silva-Matus P; Saitz-Barría C; Araya-Maturana R
    Bioorg Med Chem; 2013 Dec; 21(24):7604-11. PubMed ID: 24262884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.
    Bernotas RC; Antane S; Shenoy R; Le VD; Chen P; Harrison BL; Robichaud AJ; Zhang GM; Smith D; Schechter LE
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1657-60. PubMed ID: 20138763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
    Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 5-HT6 receptor ligands based on virtual HTS.
    Tasler S; Kraus J; Wuzik A; Müller O; Aschenbrenner A; Cubero E; Pascual R; Quintana-Ruiz JR; Dordal A; Mercè R; Codony X
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6224-9. PubMed ID: 17892934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 2-indolcarbohydrazones as potent α-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions.
    Taha M; Ismail NH; Javaid K; Imran S; Anouar el H; Wadood A; Atia-Tul-Wahab ; Ali M; Khan KM; Saad SM; Rahim F; Choudhary MI
    Bioorg Chem; 2015 Dec; 63():24-35. PubMed ID: 26398141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamides as peripheral benzodiazepine receptor ligands: synthesis, biological evaluation and 3D-QSAR investigation.
    Selleri S; Gratteri P; Costagli C; Bonaccini C; Costanzo A; Melani F; Guerrini G; Ciciani G; Costa B; Spinetti F; Martini C; Bruni F
    Bioorg Med Chem; 2005 Aug; 13(16):4821-34. PubMed ID: 15975799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
    Hayat F; Cho S; Rhim H; Indu Viswanath AN; Pae AN; Lee JY; Choo DJ; Choo HY
    Bioorg Med Chem; 2013 Sep; 21(17):5573-82. PubMed ID: 23810425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 7-phenylsulfanyl-1,2,3,4,10,10a-hexahydro-pyrazino[1,2-a]indoles as dual serotonin 5-HT2C and 5-HT6 receptor ligands.
    Krogsgaard-Larsen N; Jensen AA; Kehler J
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5431-3. PubMed ID: 20719507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel N
    Nirogi RV; Bandyala TR; Gangadasari PR; Khagga M
    J Enzyme Inhib Med Chem; 2016; 31(sup1):1-15. PubMed ID: 27806648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
    Mattsson C; Svensson P; Boettcher H; Sonesson C
    Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT(1A) receptors.
    Sukalovic V; Ignjatovic D; Tovilovic G; Andric D; Shakib K; Kostic-Rajacic S; Soskic V
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3967-72. PubMed ID: 22607670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.